The epidemiology of respiratory syncytial virus lower respiratory tract infections in children less than 5 years of age in indonesia

Pediatric Infectious Disease Journal

Volumn 30, Issue 9, 2011, Pages 778-784

  Simões, Eric A F ^a,b   Mutyara, Kuswandewi ^b   Soh, Shirlena ^c   Agustian, Dwi ^b   Hibberd, Martin L ^c   Kartasasmita, Cissy B ^b  

^a Children's Hospital Colorado   (United States)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Asthma; home visitation; longitudinal study; morbidity

Indexed keywords

ARTICLE; CHILD; FEMALE; HUMAN; INDONESIA; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RURAL POPULATION; URBAN POPULATION; VIRUS DETECTION; WHEEZING;

EID: 80051916134     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318218ab9e     Document Type: Article

References (53)

1. Williams BG, Gouws E, Boschi-Pinto C, et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002;2:25-32. (Pubitemid 36109303)
2. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893-902.
3. Nair H, Nokes DJ, Gessner BD, et al. Centre for Population Health Sciences, Global Health Academy, The University of Edinburgh, Edinburgh, UK. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545-1555.
4. Ahmad OB, Lopez AD, Inoue M. The decline in child mortality: a reappraisal. Bull World Health Organ. 2000;78:1175-1191.
5. Cunningham CK, McMillan JA, Gross SJ. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics. 1991;88:527-532.
6. Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988;82: 199-203.
7. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med. 1982;307: 397-400. (Pubitemid 12089293)
8. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126:212-219.
9. Carbonell-Estrany X, Simoes EA, Dagan R, et al. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics. 2010;125:e35-e51.
10. Feltes TF, Cabalka AK, Meissner HC, et al. Cardiac Synagis Study Group. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003;143:532-540. (Pubitemid 37352516)
11. Simoes EA. Respiratory syncytial virus infection. Lancet. 1999;354:847-852. (Pubitemid 29415599)
12. Weber MW, Dackour R, Usen S, et al. The clinical spectrum of respiratory syncytial virus disease in The Gambia. Pediatr Infect Dis J. 1998;17:224-230. (Pubitemid 28146064)
13. Cherian T, Simoes EA, Steinhoff MC, et al. Bronchiolitis in tropical south India. Am J Dis Child. 1990;144:1026-1030. (Pubitemid 20326413)
14. Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J. 2003;22:S21-S32. (Pubitemid 36228149)
15. Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine corrected for prevention of pneumonia and meningitis in Gambian infants. Lancet. 1997;349:1191-1197. (Pubitemid 27190041)
16. Gessner BD, Sutanto A, Linehan M, et al. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet. 2005;365: 43-52. (Pubitemid 40082145)
17. Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003;349:1341-1348. (Pubitemid 37186212)
18. Cutts FT, Zaman SM, Enwere G, et al. Gambian Pneumococcal Vaccine Trial Group. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;365: 1139-1146. (Pubitemid 40417563)
19. Lucero MG, Nohynek H, Williams G, et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J. 2009;28: 455-462.
20. Watt JP, Wolfson LJ, O'Brien KL, et al. Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Haemophilus influenzae type bin children younger than 5 years: global estimates. Lancet. 2009;374:903-911.
21. Borrero I, Fajardo L, Bedoya A, et al. Acute respiratory tract infections among a birth cohort of children from Cali, Colombia, who were studied through 17 months of age. Rev Infect Dis. 1990;12(suppl 8):S950-S956.
22. Weissenbacher M, Carballal G, Avila M, et al. Etiologic and clinical evaluation of acute lower respiratory tract infections in young Argentinian children: an overview. Rev Infect Dis. 1990;12(suppl 8):S889-S898.
23. Huq F, Rahman M, Nahar N, et al. Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh. Rev Infect Dis. 1990;12(suppl 8):S982-S987.
24. Rahman M, Huq F, Sack DA, et al. Acute lower respiratory tract infections in hospitalized patients with diarrhea in Dhaka, Bangladesh. Rev Infect Dis. 1990;12(suppl 8):S899-S906.
25. Vathanophas K, Sangchai R, Raktham S, et al. A community-based study of acute respiratory tract infection in Thai children. Rev Infect Dis. 1990; 12(suppl 8):S957-S965.
26. Suwanjutha S, Chantarojanasiri T, Watthana-kasetr S, et al. A study of nonbacterial agents of acute lower respiratory tract infection in Thai children. Rev Infect Dis. 1990;12(suppl 8):S923-S928.
27. Hortal M, Mogdasy C, Russi JC, et al. Microbial agents associated with pneumonia in children from Uruguay. Rev Infect Dis. 1990;12(suppl 8): S915-S922.
28. Robertson SE, Roca A, Alonso P, et al. Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bull World Health Organ. 2004;82:914-922. (Pubitemid 40065159)
29. Cherian T, John TJ, Simoes E, et al. Evaluation of simple clinical signs for the diagnosis of acute lower respiratory tract infection. Lancet. 1988;2:125-128.
30. Mulholland EK, Simoes EA, Costales MO, et al. Standardized diagnosis of pneumonia in developing countries. Pediatr Infect Dis J. 1992;11:77-81.
31. World Health Organization. Acute respiratory infections in children: case management in small hospitals in developing countries-a manual for physicians and other senior health workers. Geneva, Switzerland: World Health Organization; 1995.
32. Groothuis JR, Simoes EA, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993;329:1524-1530. (Pubitemid 23332437)
33. Hu A, Colella M, Tam JS, et al. Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J Clin Microbiol. 2003;41:149-154. (Pubitemid 36098568)
34. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med. 2005;353:2342-2351. (Pubitemid 41713746)
35. Fleiss J. Statistical Methods for Rates and Proportions. New York, NY: John Wiley and Sons; 2009.
36. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003; 143(suppl 5):S118-S126. (Pubitemid 37456909)
37. Broor S, Parveen S, Bharaj P, et al. A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India. PLoS One. 2007;2:e491.
38. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis. 2008;46:50-57. (Pubitemid 351263559)
39. Berkley JA, Munywoki P, Ngama M, et al. Kenya Medical Research Institute, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA. 2010;303:2051-2057.
40. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588-598.
41. Houben ML, Bont L, Wilbrink B, et al. Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study. Pediatrics. 2011;127:35-41.
42. Stensballe LG, Ravn H, Kristensen K, et al. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J Pediatr. 2009;154: 296-298.
43. Glezen WP, Paredes A, Allison JE, et al. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98:708-715. (Pubitemid 11070320)
44. Mlinaric-Galinovic G, Vojnovic G, et al. Does the viral subtype influence the biennial cycle of respiratory syncytial virusi Virol J. 2009;6:133.
45. Buckingham SC, Bush AJ, Devincenzo JP. Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants. Pediatr Infect Dis J. 2000;19:113-117. (Pubitemid 30111405)
46. Gueudin M, Vabret A, Petitjean J, et al. Quantitation of respiratory syncytial virus RNA in nasal aspirates of children by real-time RT-PCR assay. J Virol Methods. 2003;109:39-45. (Pubitemid 36349709)
47. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry crosssectional surveys. Lancet. 2006;368:733-743. (Pubitemid 44279052)
48. Bont L, Steijn M, Van Aalderen WM, et al. Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection. Thorax. 2004;59:512-516. (Pubitemid 38797525)
49. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2009;161:1501-1150.
50. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995;95:500-505.
51. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541-545. (Pubitemid 29381367)
52. Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119:1105-1110. (Pubitemid 46654175)
53. Singh AM, Moore PE, Gern JE, et al. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med. 2007;175:108-119. (Pubitemid 46115081)